Collagenoses and cutaneous manifestations of hepar diseases.

Collagenoses and cutaneous manifestations of hepar diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Collagenoses and cutaneous manifestations of hepar diseases. Abstract Text:

Aldona Pietrzak,Dorota Czelej,Bogus?aw Pietrzak,

The authors discuss cutaneous manifestations of some systemic diseases (collagenoses) and their connection with diseases of liver cells.

Collagenoses and cutaneous manifestations of hepar diseases. Publishing Authors By Initials

A Pietrzak,D Czelej,B Pietrzak,

For similar skin and connective tissue diseases: skin diseases research abstracts see: skin and connective tissue diseases: skin diseases research

PUBMED ID PMID:

MEDLINE DATE:

Collagenoses and cutaneous manifestations of hepar diseases. Journal Published:

PUBLICATION TYPE: Review

Journal: Annales Universitatis Mariae Curie-Sk?odowska. Sec

VOLUME: 57

Page Numbers: 415-8

Journal Abbreviation:

ISSN: 0066-2240

DAY: 21

MONTH: 01

YEAR: 2002

Collagenoses and cutaneous manifestations of hepar diseases. Information

Number of References: 12

LANGUAGE: eng

NlmUniqueID: 414101

Collagenoses and cutaneous manifestations of hepar diseases. Keywords Mesh Terms:

KEYWORDS: Skin Diseases

MESH TERMS: physiopathology

Chemical & Substance for Abstract: Collagenoses and cutaneous manifestations of hepar diseases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Collagenoses and cutaneous manifestations of hepar diseases.

AFFILIATION: Department of Dermatology, 2nd Department of Clinical Anaesthesiology, Medical University of Lublin.

Country: Poland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann Univ Mariae Curie Sklodows

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Collagenoses and cutaneous manifestations of hepar diseases Related Publications

• Clinical Significance of Pharmacokinetic Drug Interactions Between Interferon-alpha and Antineoplastic Drugs.
• Collagenoses and cutaneous manifestations of hepar diseases.
• Dega's transiliac osteotomy in the treatment of spastic hip subluxation and dislocation in cerebral palsy.
• Double osteotomy in the surgical treatment of Perthes' disease: Dega's transiliac osteotomy and subtrochanteric osteotomy.
• Etanercept in psoriasis treatment.
• Indications for psychological intervention in patients with psoriasis.
• Neurodevelopmental rehabilitation according to Glenn Doman (the Philadelphia Neurodevelopment Method).
• Plasma activity of interleukin-10 in drug-induced cutaneous reactions.
• Rapid cooling through the glass transition transiently increases ductility of PGA/PLLA copolymers: a proposed mechanism and implications for devices.
• [A new sign for the establishment of gunshot in suicide?]
• [Closure of spontaneous nasal septum defect with fascia]
• [Evaluation of outcomes following total hip arthroplasty]
• [Immunoglobulins and circulating immunologic complexes in serum of patients with psoriasis, lichen planus and pityriasis rosea]